APOBEC3A and cancer: Accurately determining the conditions under which APOBEC3A and APOBEC3B are expressed in normal and cancerous tissues represents a key challenge in building our understanding of how APOBEC-mediated mutagenesis occurs, and how they might be targeted for cancer treatment (Petljak et al, 2022b).